Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
INZY | Inozyme Pharma, Inc. | SVP, CFO & Head of BD | $197K | Mar 31, 2025 | ||
OCGN | Ocugen, Inc. | Chief Financial Officer | $105K | Jan 3, 2022 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|